FRONTLINE TRI-ACT Spot-on, solution; FRONTLINE

Boehringer Ing. Pharma GmbH & Co. KG

Revision date : 2025-10-06

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08 GHS07 GHS09
Health risk rating 5
Safety risk rating 1
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

258-067-9/52645-53-1

Name of the chemical

Permethrin

Concentration

>=30-<50

EC/CAS

212-828-1/872-50-4

Name of the chemical

N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)

Concentration

>=30-<50 >=10%

EC/CAS

424-610-5/120068-37-3

Name of the chemical

Fipronil; 5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile

Concentration

>=2,5-<10

EC/CAS

204-881-4/128-37-0

Name of the chemical

2,6-di-tert-butyl-p-cresol

Concentration

=0,1-<0,25

General Information

Version

4.3

Revision date

2025-10-06

Product name

FRONTLINE TRI-ACT Spot-on, solution; FRONTLINE

Product Synonyms

Frontect® Spot-On Dog; Certishield®; Certishield® for Dogs; Frontect® Spot-On Dog; Certishield®; Certishield® for Dogs; Triact Frontect®, Frontline® TRI-ACT 0.5 mL - 6.0 mL with API: Fipronil and Permethrin

1.2.1 Relevant identified uses

Veterinary product

1.2.2. Uses advised against

Safety Data Sheet only for the professional user., For veteri- on use nary use only, Refer to the product insert for complete instruc- tions on usage

Emergency telephone

+498007790900, +1 703-527-3887, +49800 1817059

Icons in SDS

GHS07 GHS08 GHS09 M004 M009 M010 M011 M017 M059

Company Information

company name

Boehringer Ing. Pharma GmbH & Co. KG

e-mail address of the competent person responsible for the Safety Data Sheet

EHS-Services@Boehringer-Ingelheim.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H302, H302+H332, H315, H317, H319, H332, H335, H360D, H373, H400, H410

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H302 + H332 Harmful if swallowed or if inhaled. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H360D May damage the unborn child. H373 May cause damage to organs (Central nervous system) through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.

Hazardous Ingredients

m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 1-methyl-2-pyrrolidone Fipronil

Additional information

Restricted to professional users.

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H302: Harmful if swallowed. Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Reproductive toxicity, Category 1B H360D: May damage the unborn child. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2, Central nervous longed or repeated exposure. system Short-term (acute) aquatic hazard, Cate- H400: Very toxic to aquatic life. gory 1 Long-term (chronic) aquatic hazard, Cat- H410: Very toxic to aquatic life with long lasting egory 1 effects.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.